Cell Isolation Market

The report "Cell Isolation/Separation Market by Product (Consumables [Media, Kits] Instruments), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose Tissue), Technique (Centrifugation, Filtration), Application (Biomolecule, Cancer) - Global Forecast to 2029", is projected to reach USD 8.4 billion by 2029 from an estimated USD 4.6 billion in 2024, at a CAGR of 12.9% from 2024 to 2029. Factors contributing to the growth of the global market include increasing R&D investments and funding in cell-based resaerch and growing emphasis on technological advancements. However, high cost of cell-based resaerch is expected to hinder market growth.

Browse 456 market data Tables and 62 Figures spread through 475 Pages and in-depth TOC on "Cell Isolation/Separation Market by Product (Consumables [Media, Kits] Instruments), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose Tissue), Technique (Centrifugation, Filtration), Application (Biomolecule, Cancer) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/cell-isolation-market-103931479.html

The consumables segment accounted for the largest share of the product segment in the cell isolation market in 2023.

Based on product, the cell isolation market is segmented into consumables and instruments. The consumables segment is further divided into reagents, kits, media & sera, beads, and disposables. Similarly, the instruments segment is further segmented into centrifuges, cell sorters, magnetic-activated cell seperator systems, and filtration systems. In 2023, the consumables segment dominated the market and is also expected to grow at a high CAGR during the forecast period. The largest share of the consumables segment is attributed to the increasing demand for high-quality reagents to ensure reliable and reproducible results, the repetitive purchase nature of consumables because of their single-use design, and advancements in cellular therapy.

The pharmaceutical & biotechnology companies segment is estimated to register the highest growth rate during the forecast period in the cell isolation market.

Based on end user, the cell isolation market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic laboratories, and other end users. The pharmaceutical & biotechnology companies segment is estimated to register the highest growth rate during the forecast period. The rising number of biopharmaceutical companies and growing demand for cell-based therapies due to the increasing incidence of chronic diseases such as cancer is anticipated to promote the growth of the pharmaceutical & biotechnology companies segment in coming years.

The Asia Pacific region is expected to register highest CAGR during the forecast period of 2024-2029.

Based on the region, the cell isolation market is segmented into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific is anticipated to register the fastest growth in the cell isolation market owing to the increasing focus on the development of cell-based therapies, government initiatives for infrastructural improvements of healthcare facilities, growing funding for R&D, and the booming healthcare sector. Due to their large and growing populations, India and China are expected to be the key growth hotspots in the Asia Pacific market. Over the last decade, CMOs in the Asia Pacific region have impacted the global pharmaceutical manufacturing market. Several small- and medium-scale CMOs set up in the Asia Pacific region have obtained US FDA approval for their operations and completed GMP certifications, thus driving the region’s cell isolation market.

Key players in the cell isolation market include Merck KGaA (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), BD (US), Agilent Technologies, Inc. (US), Miltenyi Biotec (Germany), Revvity (US), Sartorius AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Lonza (Switzerland), QIAGEN (Netherlands), ALFA LAVAL (Sweden), Terumo Corporation (Japan), Corning Incorporated (US), Bio-Rad Laboratories, Inc. (US), GenScript (US), Bio-Techne (US), Takara Bio Inc. (Japan), Standard BioTools (US), Promega Corporation (US), Cell Signaling Technology, Inc. (US), and STEMCELL Technologies (Canada).

Don’t miss out on business opportunities in Cell Isolation/Separation Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]